Analeah Heidt
Nessuna posizione attualmente
Profilo
Analeah Heidt worked as an Executive Vice President-Translational Research at Inhibrx, Inc.
Precedenti posizioni note di Analeah Heidt
| Società | Posizione | Fine |
|---|---|---|
| INHIBRX, INC. | Corporate Officer/Principal | 01/08/2021 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Inhibrx, Inc.
 Inhibrx, Inc. BiotechnologyHealth Technology Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA. | Health Technology |
- Borsa valori
- Insiders
- Analeah Heidt
